An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal Function
Hepatitis C virus (HCV) infection affects roughly 170 million people worldwide. Sofosbuvir/Ledipasvir (Sof/Led) is a new once daily direct acting antiviral combination pill that was approved in October 2014 for use in patients with HCV genotype 1 infection. Coadministration of Sof/Led is studied onl...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Case Reports in Medicine |
| Online Access: | http://dx.doi.org/10.1155/2016/3191089 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832567233082032128 |
|---|---|
| author | Shyam Patel Jennifer Andres Kamran Qureshi |
| author_facet | Shyam Patel Jennifer Andres Kamran Qureshi |
| author_sort | Shyam Patel |
| collection | DOAJ |
| description | Hepatitis C virus (HCV) infection affects roughly 170 million people worldwide. Sofosbuvir/Ledipasvir (Sof/Led) is a new once daily direct acting antiviral combination pill that was approved in October 2014 for use in patients with HCV genotype 1 infection. Coadministration of Sof/Led is studied only with rosuvastatin which shows significantly increased level of drug and is associated with increased risk of myopathy, including rhabdomyolysis. There is no mention of such HMG-CoA reductase inhibitor interaction as a class, as pravastatin did not have any clinically significant interaction with Sof/Led. Other myotoxic drugs, including colchicine are not studied. We present a case of a serious drug interaction between Sof/Led and atorvastatin, in the background of CKD and colchicine use. |
| format | Article |
| id | doaj-art-6919a2c920f54da48a2502500ec662d0 |
| institution | Kabale University |
| issn | 1687-9627 1687-9635 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Medicine |
| spelling | doaj-art-6919a2c920f54da48a2502500ec662d02025-02-03T01:02:01ZengWileyCase Reports in Medicine1687-96271687-96352016-01-01201610.1155/2016/31910893191089An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal FunctionShyam Patel0Jennifer Andres1Kamran Qureshi2Department of Medicine, Temple University Hospital, Philadelphia, PA 19140, USADepartment of Pharmacy Practice, Temple University School of Pharmacy, Philadelphia, PA 19140, USADepartment of Medicine, Section of Gastroenterology, Temple University Lewis Katz School of Medicine, 3440 N. Broad Street, Philadelphia, PA 19140, USAHepatitis C virus (HCV) infection affects roughly 170 million people worldwide. Sofosbuvir/Ledipasvir (Sof/Led) is a new once daily direct acting antiviral combination pill that was approved in October 2014 for use in patients with HCV genotype 1 infection. Coadministration of Sof/Led is studied only with rosuvastatin which shows significantly increased level of drug and is associated with increased risk of myopathy, including rhabdomyolysis. There is no mention of such HMG-CoA reductase inhibitor interaction as a class, as pravastatin did not have any clinically significant interaction with Sof/Led. Other myotoxic drugs, including colchicine are not studied. We present a case of a serious drug interaction between Sof/Led and atorvastatin, in the background of CKD and colchicine use.http://dx.doi.org/10.1155/2016/3191089 |
| spellingShingle | Shyam Patel Jennifer Andres Kamran Qureshi An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal Function Case Reports in Medicine |
| title | An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal Function |
| title_full | An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal Function |
| title_fullStr | An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal Function |
| title_full_unstemmed | An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal Function |
| title_short | An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal Function |
| title_sort | unexpected interaction between sofosbuvir ledipasvir and atorvastatin and colchicine causing rhabdomyolysis in a patient with impaired renal function |
| url | http://dx.doi.org/10.1155/2016/3191089 |
| work_keys_str_mv | AT shyampatel anunexpectedinteractionbetweensofosbuvirledipasvirandatorvastatinandcolchicinecausingrhabdomyolysisinapatientwithimpairedrenalfunction AT jenniferandres anunexpectedinteractionbetweensofosbuvirledipasvirandatorvastatinandcolchicinecausingrhabdomyolysisinapatientwithimpairedrenalfunction AT kamranqureshi anunexpectedinteractionbetweensofosbuvirledipasvirandatorvastatinandcolchicinecausingrhabdomyolysisinapatientwithimpairedrenalfunction AT shyampatel unexpectedinteractionbetweensofosbuvirledipasvirandatorvastatinandcolchicinecausingrhabdomyolysisinapatientwithimpairedrenalfunction AT jenniferandres unexpectedinteractionbetweensofosbuvirledipasvirandatorvastatinandcolchicinecausingrhabdomyolysisinapatientwithimpairedrenalfunction AT kamranqureshi unexpectedinteractionbetweensofosbuvirledipasvirandatorvastatinandcolchicinecausingrhabdomyolysisinapatientwithimpairedrenalfunction |